SCHEMBL3837529

SCHEMBL3837529

Cc1ccc(C#Cc2cccnc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 7/20 0.62
CYP2A6 P11509 6/20 0.56
CYP2D6 P10635 3/20 0.56
CYP1A2 P05177 2/20 0.56
CHRNB2 P17787 3/20 0.53
CHRNA4 P43681 3/20 0.53
CYP2C9 P11712 3/20 0.53
CYP2B6 P20813 3/20 0.53
CYP2C19 P33261 3/20 0.53
CYP2E1 P05181 2/20 0.52
CYP3A4 P08684 2/20 0.52
FFAR1 O14842 1/20 0.51
CYP2C8 P10632 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13907278 0.89 CYP2A6 (0.62) GRM5CYP2A6CYP2D6CYP1A2CHRNB2
SCHEMBL3796332 0.85 CYP2A6 (0.67) GRM5CYP2A6CYP2D6CYP1A2CHRNB2
SCHEMBL31673222 0.83 GRM5 (0.64) GRM5CYP2A6CYP2D6CYP1A2CHRNB2
SCHEMBL401836 0.83 GRM5 (0.64) GRM5CYP2A6CYP2D6CYP1A2CHRNB2
SCHEMBL24416463 0.82 GRM5 (0.56) GRM5CYP2A6CYP2D6CYP1A2CHRNB2
SCHEMBL31673242 0.81 CYP2A6 (0.58) GRM5CYP2A6CYP2D6CYP1A2CHRNB2
SCHEMBL1476990 0.81 GRM5 (0.71) GRM5CYP2A6CYP2D6CYP1A2CHRNB2
SCHEMBL31673182 0.81 GRM5 (0.71) GRM5CYP2A6CYP2D6CYP1A2CHRNB2
SCHEMBL31673257 0.81 GRM5 (0.54) GRM5CYP2A6CYP2D6CYP1A2CHRNB2
SCHEMBL31673355 0.80 GRM5 (0.58) GRM5CYP2A6CYP2D6CYP1A2CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1729771-B1 PYRIDYL DERIVATIVES AND THEIR USE AS MGLU5 RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-14 EP claimed
EP-1729771-B1 PYRIDYL DERIVATIVES AND THEIR USE AS MGLU5 RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-14 EP disclosed